Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:718196rdf:typepubmed:Citationlld:pubmed
pubmed-article:718196lifeskim:mentionsumls-concept:C0023434lld:lifeskim
pubmed-article:718196lifeskim:mentionsumls-concept:C0346053lld:lifeskim
pubmed-article:718196pubmed:issue10lld:pubmed
pubmed-article:718196pubmed:dateCreated1979-1-15lld:pubmed
pubmed-article:718196pubmed:abstractTextAtypical fibroxanthoma (AFX) is one of a group of cutaneous lesions with a malignant histological appearance but a generally benign clinical course. A 79-year-old white man had AFX of the cheek that recurred and metastasized to buccal and cervical lymph nodes three months after initial diagnosis. When careful physical and and laboratory examinations were done, the patient was found to have concomitant chronic lymphatic leukemia, "null cell" type. In view of the low incidence of metastasizing AFX and the increased occurrence of tumors in patients with lymphomatous disorders, an important association is suggested. Before establishing the prognosis for patients with pseudomalignancies of the skin, an evaluation of their general health and immunological status should be made.lld:pubmed
pubmed-article:718196pubmed:languageenglld:pubmed
pubmed-article:718196pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:718196pubmed:citationSubsetAIMlld:pubmed
pubmed-article:718196pubmed:statusMEDLINElld:pubmed
pubmed-article:718196pubmed:monthOctlld:pubmed
pubmed-article:718196pubmed:issn0003-987Xlld:pubmed
pubmed-article:718196pubmed:authorpubmed-author:FischerJJlld:pubmed
pubmed-article:718196pubmed:authorpubmed-author:KempJ DJDlld:pubmed
pubmed-article:718196pubmed:authorpubmed-author:StennK SKSlld:pubmed
pubmed-article:718196pubmed:authorpubmed-author:AronsMMlld:pubmed
pubmed-article:718196pubmed:issnTypePrintlld:pubmed
pubmed-article:718196pubmed:volume114lld:pubmed
pubmed-article:718196pubmed:ownerNLMlld:pubmed
pubmed-article:718196pubmed:authorsCompleteYlld:pubmed
pubmed-article:718196pubmed:pagination1533-5lld:pubmed
pubmed-article:718196pubmed:dateRevised2008-3-17lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-H...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-S...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-A...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-M...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-L...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-F...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-N...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-L...lld:pubmed
pubmed-article:718196pubmed:meshHeadingpubmed-meshheading:718196-N...lld:pubmed
pubmed-article:718196pubmed:year1978lld:pubmed
pubmed-article:718196pubmed:articleTitleMetastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukemia.lld:pubmed
pubmed-article:718196pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:718196pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:718196lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:718196lld:pubmed